Ian Smith - EVP, Vertex Pharmaceuticals Inc / Ma

As of July 3, 2018


What is Ian Smith's Net Worth?

The current estimated net worth of Vertex Pharmaceuticals Inc / Ma's EVP, Ian Smith, is estimated to be about $177.81M . Ian Smith owns about 52,005 units of Vertex Pharmaceuticals Inc / Ma common stock. In the last 15 years at Vertex Pharmaceuticals Inc / Ma, Ian Smith has sold an estimated value of $164.77M worth.

What is Ian Smith's Past Insider Trading?

Ian Smith's largest purchase order was 739,643 units , worth over $25.55M on April 23, 2013. Ian Smith's largest sale order was 745,685 units , worth over $60.96M on April 23, 2013. In total, Ian Smith has made about 91 transactions over 15 years of their time at Vertex Pharmaceuticals Inc / Ma. Ian Smith usually trades in May, with the busiest year in 2017. The most recent transaction was a sale order of 23,375 units , worth over $3.89M on July 3, 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Ian Smith's' Mailing Address?

  • Mailing address is C/o Acorda Therapeutics, Inc. 420 Saw Mill River Road Ardsley NY 10502 NY

What are Vertex Pharmaceuticals Inc / Ma's Past Insider Trades?

Vertex Pharmaceuticals Inc / Ma's most recent insider trade came on May 18, 2022 by Bastiano Sanna who sold 45 units worth $11.38K . In the last 19 years, insiders at Vertex Pharmaceuticals Inc / Ma have sold an estimated value of $1.61B and bought an estimated value of $522.29M worth of shares. Insider trading is most common in February, with the busiest year in 2015. The most active traders at the company are Joshua Boger, Director,  Paul Silva, SVP & Chief Accounting Officer,  and Amit Sachdev, EVP .

VERTEX PHARMACEUTICALS INC / MA Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1